# Healthy volunteers needed for CBD research – JHU Hub – Johns Hopkins University > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/healthy-volunteers-needed-for-cbd-research-jhu-hub-johns-hopkins-university/ > **Published:** 2026-05-20T10:03:39-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:54:42-04:00 > **Clinical Summary:** Johns Hopkins recruiting healthy volunteers for CBD clinical research studies. Three-visit lab protocol at Bayview Medical Center advances cannabis science evidence. --- ✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CBDResearchSafetyMental HealthAnxietyHempDosing Why This Matters This Johns Hopkins study will generate clinical evidence on CBD’s effects in human subjects, directly informing clinicians’ ability to counsel patients on safety and efficacy beyond anecdotal reports. As CBD use among patients continues to rise, research data from controlled studies becomes essential for evidence-based recommendations and identification of potential drug interactions or adverse effects. Clinicians who understand the emerging evidence from such rigorous trials can better address patient questions about CBD and integrate findings into informed decision-making around [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/). Clinical Summary Johns Hopkins University is recruiting healthy volunteers with prior cannabis or CBD experience for a [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) study conducted at Bayview Medical Center, requiring three laboratory visits to investigate the effects and mechanisms of cannabidiol. While the article provides limited detail about the study’s specific aims and methodology, such research is important for establishing the safety profile, pharmacokinetics, and potential therapeutic applications of CBD in controlled human subjects rather than relying solely on preclinical or observational data. This type of investigator-initiated research at academic medical centers helps fill evidence gaps that can inform clinical decision-making and regulatory pathways for cannabis-derived products. For clinicians considering CBD for their patients, participation in rigorous [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) contributes to the growing body of evidence needed to move beyond anecdotal reports and establish reproducible safety and efficacy data. Clinicians and patients interested in evidence-based [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) should encourage participation in such institutional research studies and monitor published findings to inform their own treatment decisions. Dr. Caplan’s Take “We need rigorous, well-controlled studies like Johns Hopkins is conducting because right now patients are making decisions about CBD based on anecdote and marketing rather than evidence, and as clinicians we’re left trying to separate signal from noise in our counseling.” Clinical Perspective As cannabidiol (CBD) research continues to expand at major academic medical centers, clinicians should recognize that participation in controlled studies helps establish the safety and efficacy data needed to guide future clinical recommendations. This Johns Hopkins recruitment effort represents important investigational work, though it’s worth noting that volunteer-based study populations may not fully represent patients with comorbidities or concurrent medications that practitioners encounter in real-world settings. The gap between healthy volunteer research and clinical applicability remains significant, particularly given the substantial individual variability in CBD metabolism and the limited understanding of long-term effects across diverse patient populations. Clinicians should stay informed about emerging CBD research findings while remaining cautious about patient requests for CBD use, as evidence from healthy volunteer studies often precedes definitive clinical guidance by several years. Until robust efficacy data accumulate for specific conditions, practitioners should continue to individualize CBD discussions, document their clinical reasoning, and advise patients that “research is ongoing 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Healthy%20volunteers%20needed%20for%20CBD%20research%20-%20JHU%20Hub%20-%20Johns%20Hopkins%20University%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55806)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55806)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Healthy%20volunteers%20needed%20for%20CBD%20research%20-%20JHU%20Hub%20-%20Johns%20Hopkins%20University%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55806)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://hub.jhu.edu/announcements/2026/05/19/healthy-volunteers-needed-for-cbd-research/](https://hub.jhu.edu/announcements/2026/05/19/healthy-volunteers-needed-for-cbd-research/) Further Reading Cannabis Policy Wire[Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I](https://cedclinic.com/mdmb-4en-pinaca-schedule-i-placement/) CED Clinic Blog[Fear of recurrence, secondary cancers, and health problems in long-term survivors of childhood cancer: Findings from a Canadian cohort.](https://cedclinic.com/fear-of-recurrence-secondary-cancers-and-health-problems-in-long-term-survi/) CED Clinic Blog[Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical cannabis patients across 45 days.](https://cedclinic.com/associations-of-cannabis-use-other-substances-and-lifestyle-choices-on-anxi/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).